Inhaled Nitric Oxide

The purpose of this sources sought notice is to conduct market research to determine if responsible sources exist by determining if this effort can be successfully competed and/or set-aside for Small Businesses. The proposed North American Industry Classification System (NAICS) Code is 325413 – In-Vitro Diagnostics Substance Manufacturing which has a size standard of 1,250 employees. The Government will use this information to determine the best acquisition strategy for this procurement. The Government is interested in all large and small businesses to include 8(a), Service-Disabled Veteran-Owned, HubZone, and Women-Owned small business concerns.

The Medical Readiness Contracting Office-West (MRCO-W), JBSA, Fort Sam Houston, Texas, is seeking potential sources to establish an Inhaled Nitric Oxide Gas contract in support of the Respiratory Department at Brooke Army Medical Center (BAMC), JBSA – Fort Sam Houston, Texas.

This requirement is for the purchase of inhaled Nitric Oxide (iNO) to be used in various clinics within Brooke Army Medical Center (BAMC) to improve oxygenation for patients undergoing various procedures. The Inhaled Nitric Oxide must adhere to the entirety of the list of salient characteristics outlined in Attachment (1). Period of Performance: One (1) base year (01 JAN 2027 – 31 DEC 2027) plus four (4) option years (01 JAN 2028 - 31 DEC 2032).

This is not a solicitation. This information is for planning purposes only and is not to be construed as a commitment by the Government, implied or otherwise, to issue a solicitation or award a contract. Contractors responding to this sources sought notice are advised their response does not ensure participation in future solicitations or contract awards. The Government will not reimburse any company or individual for any expense associated with preparation or participation in this research. Interested parties should e-mail responses to jaclyn.v.evans.civ@health.mil.